Wedmont Private Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
19,243
+2,073
+12% +$119K 0.03% 323
2026
Q1
$1.02M Sell
17,170
-2,086
-11% -$122K 0.03% 312
2025
Q4
$1.09M Buy
19,256
+5,588
+41% +$269K 0.04% 267
2025
Q3
$610K Sell
13,668
-768
-5% -$35.9K 0.02% 401
2025
Q2
$688K Buy
14,436
+3,074
+27% +$151K 0.03% 352
2025
Q1
$576K Buy
11,362
+875
+8% +$51K 0.03% 342
2024
Q4
$586K Buy
10,487
+2,392
+30% +$134K 0.03% 327
2024
Q3
$433K Buy
8,095
+999
+14% +$46.9K 0.02% 405
2024
Q2
$287K Sell
7,096
-1,857
-21% -$83.1K 0.02% 508
2024
Q1
$462K Sell
8,953
-716
-7% -$36.5K 0.03% 337
2023
Q4
$501K Sell
9,669
-4,553
-32% -$239K 0.04% 308
2023
Q3
$805K Buy
14,222
+169
+1% +$10.4K 0.08% 159
2023
Q2
$870K Sell
14,053
-1,023
-7% -$68.6K 0.09% 147
2023
Q1
$1.06M Buy
15,076
+545
+4% +$38.4K 0.14% 102
2022
Q4
$1.06M Buy
14,531
+2,712
+23% +$204K 0.16% 95
2022
Q3
$840K Buy
11,819
+96
+0.8% +$6.96K 0.17% 98
2022
Q2
$903K Buy
11,723
+2,110
+22% +$161K 0.19% 76
2022
Q1
$709K Buy
9,613
+3,076
+47% +$207K 0.16% 109
2021
Q4
$422K Buy
+6,537
New +$383K 0.13% 127

Other funds holding BMY

Wedmont Private Capital's BMY Position: Q2 2026 in Review

Wedmont Private Capital increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $119K and bringing the position to 19,243 shares worth $1.11M. The position accounts for 0.03% of the portfolio, ranked #323.

Wedmont Private Capital first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wedmont Private Capital held 19,243 shares of Bristol-Myers Squibb worth $1.11M as of Q2 2026.
  • Wedmont Private Capital bought 2,073 Bristol-Myers Squibb shares in Q2 2026, an estimated $119K.
  • Bristol-Myers Squibb made up 0.03% of Wedmont Private Capital's portfolio in Q2 2026, its #323 holding.
  • Wedmont Private Capital first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.